In vivo efficacy of meglumine antimoniate-loaded nanoparticles for cutaneous leishmaniasis: a systematic review

Enhanced antibacterial and antiparasitic activity of multifunctional polymeric nanoparticles

(2020) Saliha Durak et al.   NANOTECHNOLOGY

The ARRIVE guidelines 2.0: Updated guidelines for reporting animal research

(2020) Nathalie Percie du Sert et al.   BRITISH JOURNAL OF PHARMACOLOGY

American tegumentary leishmaniasis in Brazil: a critical review of the current therapeutic approach with systemic meglumine antimoniate and short-term possibilities for an alternative treatment

(2019) Sílvia H. Carvalho et al.   TROPICAL MEDICINE & INTERNATIONAL HEALTH

Cutaneous Leishmaniasis

(2019) Naomi E. Aronson et al.   INFECTIOUS DISEASE CLINICS OF NORTH AMERICA

The activity of encapsulated meglumine antimoniate in stearylamine-bearing liposomes against cutaneous leishmaniasis in BALB/c mice

(2019) Seyedeh Alia Moosavian et al.   EXPERIMENTAL PARASITOLOGY

Development and Characterization of a Semi-Solid Dosage Form of Meglumine Antimoniate for Topical Treatment of Cutaneous Leishmaniasis

(2019) Diana Berenguer et al.   Pharmaceutics

Applications of Nanomaterials in Leishmaniasis: A Focus on Recent Advances and Challenges

(2019) Kiran Saleem et al.   Nanomaterials

Chitosan-titanium dioxide-glucantime nanoassemblies effects on promastigote and amastigote of Leishmania major

(2018) Jaleh Varshosaz et al.   INTERNATIONAL JOURNAL OF BIOLOGICAL MACROMOLECULES

Biosynthesis, characterization and leishmanicidal activity of a biocomposite containing AgNPs-PVP-glucantime

(2018) Ana Patricia Cacua Gélvez et al.   Nanomedicine

Leishmaniasis

(2018) Sakib Burza et al.   LANCET

Amphotericin B-loaded nanoparticles for local treatment of cutaneous leishmaniasis

(2018) Aiman Abu Ammar et al.   Drug Delivery and Translational Research

Cutaneous Manifestations of Human and Murine Leishmaniasis

(2017) Breanna Scorza et al.   INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES

The Role of Reactive Oxygen Species (ROS) in the Biological Activities of Metallic Nanoparticles

(2017) Ahmed Abdal Dayem et al.   INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES

Recent advances on liposomal nanoparticles: synthesis, characterization and biomedical applications

(2017) Yunes Panahi et al.   Artificial Cells Nanomedicine and Biotechnology

Evaluation of the in vivo leishmanicidal activity of amphotericin B emulgel: An alternative for the treatment of skin leishmaniasis

(2016) Iluska Martins Pinheiro et al.   EXPERIMENTAL PARASITOLOGY

Silver Nanoparticles: Synthesis, Characterization, Properties, Applications, and Therapeutic Approaches

(2016) Xi-Feng Zhang et al.   INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES

Polarity-sensitive nanocarrier for oral delivery of Sb(V) and treatment of cutaneous leishmaniasis

(2016) Juliane Lanza et al.   International Journal of Nanomedicine

Nanoscaled hydrated antimony (V) oxide as a new approach to first-line antileishmanial drugs

(2016) Antonia M.R. Franco et al.   International Journal of Nanomedicine

Development of PLGA–PEG encapsulated miltefosine based drug delivery system against visceral leishmaniasis

(2016) Rishikesh Kumar et al.   Materials Science & Engineering C-Materials for Biological Applications

Study of Leishmania pathogenesis in mice: experimental considerations

(2016) Corinne Loeuillet et al.   Parasites & Vectors

Activity and in vivo tracking of Amphotericin B loaded PLGA nanoparticles

(2015) A.C.O. Souza et al.   EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY

The immunomodulatory effects of titanium dioxide and silver nanoparticles

(2015) Courtney M. Lappas   FOOD AND CHEMICAL TOXICOLOGY

Designing polymers with sugar-based advantages for bioactive delivery applications

(2015) Yingyue Zhang et al.   JOURNAL OF CONTROLLED RELEASE

SYRCLE’s risk of bias tool for animal studies

(2014) Carlijn R Hooijmans et al.   BMC Medical Research Methodology

Use of topical liposomes containing meglumine antimoniate (Glucantime) for the treatment of L. major lesion in BALB/c mice

(2014) S.A. Moosavian Kalat et al.   EXPERIMENTAL PARASITOLOGY

Nanotechnological Strategies for the Treatment of Neglected Diseases

(2013) Najeh Khalil et al.   CURRENT PHARMACEUTICAL DESIGN

Investigation of antileishmanial activities of Tio2@Ag nanoparticles on biological properties of L. tropica and L. infantum parasites, in vitro

(2013) Adil M. Allahverdiyev et al.   EXPERIMENTAL PARASITOLOGY

Development of liposomes loaded with anti-leishmanial drugs for the treatment of cutaneous leishmaniasis

(2013) Arash Momeni et al.   JOURNAL OF LIPOSOME RESEARCH

Nano-based antileishmanial agents: A toxicological study on nanoparticles for future treatment of cutaneous leishmaniasis

(2013) Ali Jebali et al.   TOXICOLOGY IN VITRO

Leishmaniasis: Prevention, Parasite Detection and Treatment

(2012) T. Kobets et al.   CURRENT MEDICINAL CHEMISTRY

Cutaneous and Mucocutaneous Leishmaniasis

(2012) Hiro Goto et al.   INFECTIOUS DISEASE CLINICS OF NORTH AMERICA

Internalization of paramagnetic phosphatidylserine-containing liposomes by macrophages

(2012) Tessa Geelen et al.   JOURNAL OF NANOBIOTECHNOLOGY

Antimicrobial effects of TiO2and Ag2O nanoparticles against drug-resistant bacteria andleishmaniaparasites

(2011) Adil M Allahverdiyev et al.   Future Microbiology

Uptake and antileishmanial activity of meglumine antimoniate-containing liposomes in Leishmania (Leishmania) major-infected macrophages

(2011) Samanta Etel Treiger Borborema et al.   INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS

Therapy with Sodium Stibogluconate in Stearylamine-Bearing Liposomes Confers Cure against SSG-Resistant Leishmania donovani in BALB/c Mice

(2011) Jayeeta Roychoudhury et al.   PLoS One

Metabolic Pathways Required for the Intracellular Survival of Leishmania

(2010) Malcolm J. McConville et al.   Annual Review of Microbiology

Leishmaniasis: Current Treatment and Prospects for New Drugs and Vaccines

(2009) Lukasz Kedzierski et al.   CURRENT MEDICINAL CHEMISTRY